Abbott Laboratories (ABT)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 47,664,000 | 38,603,000 | 36,686,000 | 35,802,000 | 32,784,000 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $47,664,000K)
= 0.00
The debt-to-capital ratio for Abbott Laboratories has remained consistently at 0.00 from December 31, 2020, to December 31, 2024. This indicates that Abbott Laboratories has not utilized debt financing to fund its operations or growth during this period. A debt-to-capital ratio of 0.00 suggests that the company's capital structure is primarily composed of equity, which can be considered a positive sign of financial stability and lower financial risk. Overall, Abbott Laboratories appears to have a conservative approach to debt financing, maintaining a strong financial position with a low reliance on debt to support its operations and investments.
Peer comparison
Dec 31, 2024